Monoclonal antibodies against c-Met
US11512140B2 · kind B2 · utility
0Cited by
21References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2019 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Nov 1, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.